Abstract
Photodynamic therapy (PDT) is a therapeutic modality that utilizes a photosensitizing drug that selectively localizes in tumors and, on activation by exposure to light, results in preferential tumor necrosis. Like all new therapies directed to cancer, this modality was initially greeted with great enthusiasm and was heralded as an excellent therapy, not only for early superficial cancer but also the more advanced tumors. Time and experience have tempered this unrealistic expectation and, therefore, in spite of its initial promise, PDT remains for the present an investigational modality whose potential has yet to be realized. Much basic research and more clinical trials are required before its exact role in contemporary cancer therapy can be accurately defined, but one remains optimistic that this will soon occur. Two components are necessary for this therapy to be utilized, that is, a photosensitizer drug and a laser to activate the drug.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Castro DJ, Saxton ER, Fetterman H. New concepts in photodynamic therapy with lasers. In: W Fee, H Geopfert, M Johns, eds. Head and Neck Cancer, Vol. 2. Philadelphia: B.C. Decker, 1988, pp 400–408.
Tappenier H, Jesionek A. Theropeutische reosuche met floureszierenden stoff. Muench Med Wochsder 1:2042, 1903.
Wieman TJ, Mang TS, Fingar UH. Effect of photodynamic therapy on blood flow in normal and tumor blood vessels. Surgery 104:512–517, 1990.
Bellnier DA, Lin LW, Parrish JA. Hematoporphyrin derivative and pulse laser photoradiation, porphyrin localization and treatment of tumors. In: Photodynamic Therapy. New York: Alan R. Liss, 1984, pp 533–540.
Ainsworth MD, Piper JA. Laser systems for photodynamic therapy. In: G Morstyn, A Kaye, eds. Phototherapy of Cancer. New York: Harwood Academic, 1990, pp 37–72.
Dougherty TJ, Potter WR, Belhier D. Photodynamic therapy for the treatment of cancer: Current status and advances. In: D Kessel, ed. Photodynamic Therapy of Neoplastic Disease. Boca Raton, FC: CRC Press, 1990, pp 1–19.
Gomer CJ. Photodynamic therapy in the treatment of malignancies. Semin Hematol 26:27–34, 1989.
Fingar UH, Wieman KW. Role of thromboxane and prostacyclin release on photodynamic therapy-induced tumor destruction. Cancer Res 50:2599–2603, 1990.
Marcus S. Photodynamic therapy of human cancer. Proc IEEE 80:1–21, 1992.
Waldow SM, Henderson BW, Dougherty TJ. Potentiation of phototherapy by heat. Lasers Surg Med 5:83–99, 1985.
Keller G. Photodynamic laser therapy. Arch Otolaryngol Head Neck Surg 118:15–16, 1992.
Gilson D, Asl D, Drirer J, et al. Therapeutic ratio of photodynamic therapy in the treatment of superficial tumors of skin and subcutaneous tissues in man. Br J Cancer 58:665–669, 1988.
Robinson PJ, Carruth JAS, Fairris GM. Photodynamic therapy: A better treatment for widespread Bowen’s disease. Br J Dermatol 199:59–61, 1988.
Dougherty T. Photoradiation therapy for cutaneous and subcutaneous malignancies. J Invest Dermatol 77:122–123, 1981.
McCaughan JS Jr, Guy JT, Hicks WM, et al. Photodynamic therapy for cutaneous and subcutaneous malignant neoplasms. Arch Surg 124:211–116, 1989.
Schuh M, Nseyo UO, Potter W, et al. Photodynamic therapy for palliation of locally recurrent breast carcinoma. J Clin Oncol 5:1766–1770, 1987.
Waldow SM, Lobraico RV, Kohler IK, et al. Photodynamic therapy for treatment of malignant cutaneous lesions. Lasers Surg Med 7:451–456, 1987.
Carruth JAS, McKenzie AL. Preliminary report of a pilot study of photoradiation therapy for the treatment of superficial malignancies of the skin, head, and neck. Eur J Surg Oncol 11:47–50.
Tokuda Y. Primary skin cancer. In: Y Hayata, TJ Dougherty, Igaku-Sloin, eds. Lasers and Hematoporphyrin Derivative In Cancer. Tokyo: New York: Igaku-Shoin, 1983, pp 88–96.
Pennington DJ, Waner M, Knox A. Photodynamic therapy for multiple skin cancers. Plast Reconst Surg 82:1067–1071, 1987.
Wilson BD, Mang TS, Cooper MC, et al. Use of photodynamic therapy for the treatment of extensive basal cell carcinomas. Facial Plastic Surg 6:185–189, 1989.
Tse DT, Kersten RC, Anderson RL. Hematoporphyrin derivative photoradiation therapy in managing nevoid basal cell carcinoma syndrome. Arch Ophthalmol 102:990–994, 1984.
Keller GS, Razum NJ, Dorion D. Photodynamic therapy for non-melanoma skin cancer. Fac Plast Surg 6:180–184, 1989.
Forbes I, Cowled A, Leong AS-Y, et al. Phototherapy of human tumors using hematoporphyrin derivative. Med J Aust 2:489–493, 1980.
Schuller DE, McCaughan JS, Rock RP. Photoradiation in head and neck cancer. Arch Otolaryngol 3:351–355, 1985.
Wile AG, Novotny J, Mason GR. Photoradiation therapy of head and neck cancer. Am J Clin Oncol 6:39–63, 1984.
Schweitzer VG. Photodynamic therapy for treatment of head and neck cancer. Otolaryngol Head Neck Surg 102:255–232, 1990.
McCaughan JS, Nims TA, Guy JT. Photodynamic therapy for esophageal tumors. Arch Surg 124:74–80, 1989.
Likier HM, Levine JG, Lightdale C. Photodynamic therapy for completely obstructing esophageal carcinoma. Gastrointest Endosc 37:75–78, 1991.
Gluckman JL. Hematoporphyrin photodynamic therapy: Is there truly a future in head and neck oncology? Reflections on a five year experience. Laryngoscope 101:36–42, 1991.
Wenig BL, Kurtzman DM, Grossweiner L, et al. Photodynamic therapy in the treatment of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 116:1267–1270, 1990.
Grossweiner L, Hill J, Lobraico R. Photodynamic therapy for head and neck squamous cell carcinoma: Optical dosimetry and clinical trial. Photochem Photobiol 46:911–917, 1987.
Zhao F, Zhang K, Huang H, et al. Use of hematoporphyrin derivative as a sensitizer for radiotherapy of oral and maxillofacial tumors. Lasers Med Sci 1:253–256, 1986.
Freche C, DeCorbiere S. Use of photodynamic therapy in the treatment of vocal cord carcinoma. J Photochem Photobiol 6:291–296, 1990.
Schweitzer VG, Visscher D. Photodynamic therapy for treatment of AIDS-related Kaposi’s sarcoma. Otolaryngol Head Neck Surg 102:639–649, 1990.
Marchesini R, Melloni E, Dasdia T, et al. Photosensitizing properties of rhodamine-123 on different human tumor cell lines. Laser Surg Med 6:163, 1986.
Castro DJ, Saxton RE, Fetterman HR. Rhodamine-123 as a new photochemosensitizing agent with the argon laser: ‘Non-thermal’ and thermal effects on human squamous carcinoma cells in vitro. Laryngscope 97:554–561, 1987.
Kessel D, Thompson P. Photosensitization of leukemia L1210 cells with diaziquone. Cancer Res 46:5587–5588, 1986.
Wang MX, Huo LM, Yang HC, et al. An experimental study of the photodynamic activity of berberine in vitro on cancer cells. J Trad Chin Med 6:125–127, 1986.
Oseroff AR, Ohuoha D, Ara G, et al. Intramitochrondrial dyes allow selective in vitro photolysis of carcinoma cells. Proc Natl Acad Sci USA 83:9729–9733, 1986.
Oseroff AR, Ohuoha D, Ara G, et al. Selective photochemotherapy of melanoma and human squamous cell carcinoma using cationic photosensitizers (abstr). J Invest Dermatol 88:510, 1987.
Sacchini V, Melloni E, Marchesini R, et al. Topical administration of tetrasodium-meso-tetraphenyl-porphinesulfonate (TPPS) and red light irradiation for the treatment of superficial neoplastic lesions. Tumori 73:19–23, 1987.
Van Lier JE, Brasseur N, Ali H, et al. Sulfonated metallophthalocyanines: New agents for photodynamic therapy. Lasers Surg Med 6:230–231, 1986.
Straight RC, Spikes JD, et al. Phthalocyanine dyes as photodynamic sensitizers in-vivo: Localization, retention and photoxicity in a mouse tumor model. Photochem Photobiol 43(Suppl):638 (abstract), 1986.
Dorion DR. Future directions in photodynamic therapy. Fac Plast Surg 6:190–192, 1989.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media New York
About this chapter
Cite this chapter
Gluckman, J.L., Portugal, L.G. (1995). Photodynamic therapy for cancer of the head and neck. In: Hong, W.K., Weber, R.S. (eds) Head and Neck Cancer. Cancer Treatment and Research, vol 74. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2023-8_9
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2023-8_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5837-4
Online ISBN: 978-1-4615-2023-8
eBook Packages: Springer Book Archive